SCHEMBL7080988

SCHEMBL7080988

CCNC(=O)Nc1cccc(CCc2ccc(S(=O)(=O)CC(CC(=O)O)c3ccccc3)cc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 4/20 0.44
ITGAV P06756 4/20 0.44
CA2 P00918 3/20 0.44
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA9 Q16790 2/20 0.44
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
RAB9A P51151 1/20 0.42
RORC P51449 2/20 0.41
LMNA P02545 2/20 0.41
ALDH1A1 P00352 2/20 0.41
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ITGB1 P05556 1/20 0.39
ITGA4 P13612 1/20 0.39
GHSR Q92847 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7078388 0.87 NAMPT (0.44) ITGB3ITGAVCA2CA12CA1
SCHEMBL7078041 0.83 RORC (0.47) RORCLMNAALDH1A1CYP2C9ATM
SCHEMBL7080966 0.81 KDR (0.47) MEN1KMT2ANPC1RAB9ALMNA
SCHEMBL10279296 0.81 CA12 (0.40) CA2CA12CA1CA9RORC
SCHEMBL7130423 0.81 RORC (0.44) NPC1MAPTRAB9ARORCLMNA
SCHEMBL7078136 0.81 MMP2 (0.58) CA2CA12CA1CA9
SCHEMBL8360105 0.80 RORC (0.43) CA2CA12CA1CA9RORC
SCHEMBL7079926 0.79 MAOA (0.48) CA2CA1CA9ALDH1A1ATM
SCHEMBL7130131 0.79 ITGB3 (0.46) ITGB3ITGAVMAPTALDH1A1HTT
SCHEMBL7130143 0.77 ALDH1A1 (0.37) CA2CA12CA1CA9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003059872-A1 AVB3 AND AVB5 INTEGRIN ANTAGONISTS AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH AVB3 AND AVB5 INTEGRINS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-24 WO disclosed